European Union Drugs Agency. (2025) European toolkit for the elimination of viral hepatitis in prisons (EuroHePP). Lisbon: EUDA.

European Union Drugs Agency. (2025) Viral hepatitis elimination barometer among people who inject drugs in Europe.

European Union Drugs Agency. (2025) Health and social responses: provision of harm reduction equipment for high-risk drug use.

European Union Drugs Agency. (2025) Assessing the threat posed by the increased availability, use and harms of highly potent synthetic opioids in the Baltic region. Lisbon: EUDA.

European Union Drugs Agency. (2025) Dashboard: Prevalence of cocaine use in Europe.

European Union Drugs Agency. (2025) Drug supply, production and precursors – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

European Union Drugs Agency. (2025) Drug-induced deaths – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

European Union Drugs Agency. (2025) Drug-related infectious diseases – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

European Union Drugs Agency. (2025) EUDA initial report on the new psychoactive substance 2-methylmethcathinone (2-MMC). Lisbon: EUDA.

European Union Drugs Agency. (2025) EUDA initial report on the new psychoactive substance 4-bromomethcathinone (4-BMC). Lisbon: EUDA.

European Union Drugs Agency. (2025) EUDA initial report on the new psychoactive substance N-ethylnorpentedrone (NEP). Lisbon: EUDA.

European Union Drugs Agency. (2025) EUDA statistical bulletin - data and statistics on the drug situation in Europe.

European Union Drugs Agency. (2025) European drug report 2025: trends and developments. Lisbon: European Union Drugs Agency.

European Union Drugs Agency. (2025) Harm reduction – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

European Union Drugs Agency. (2025) Heroin and other opioids – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

European Union Drugs Agency. (2025) MDMA – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

European Union Drugs Agency. (2025) New psychoactive substances – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

European Union Drugs Agency. (2025) Other drugs – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

European Union Drugs Agency. (2025) Understanding Europe’s drug situation in 2024 – key developments (European Drug Report 2025). Lisbon: EUDA.

European Union Drugs Agency. (2025) EUDA Consolidated annual activity report 2024 – key achievements and governance: a year in review. Luxembourg: Publications Office of the European Union.

European Union Drugs Agency. (2025) EU drug market: MDMA.

European Union Drugs Agency. (2025) Wastewater analysis and drugs — a European multi-city study.

European Union Drugs Agency. (2025) European web survey on drugs (EWSD) 2024.

European Union Drugs Agency. (2025) Drug-related infectious diseases.

European Union Drugs Agency. (2025) Prevention topics overview.

European Union Drugs Agency. (2025) Synthetic cannabinoids.

European Union Drugs Agency. (2024) Drug policy evaluation in Europe — topic overview.

European Union Drugs Agency. (2024) EUDA webinar: Responses for drugs in prisons — implications for Latin America, Caribbean and Europe. EUDA.

European Union Drugs Agency. A new network of forensic and toxicology laboratories to strengthen EU preparedness on drugs. (12 Nov 2024)

European Union Drugs Agency, Robert Koch Institut. (2024) Drug-related infectious diseases (DRID) technical protocol – surveys on HIV and viral hepatitis in people who inject drugs. Lisbon: EUDA.

European Union Drugs Agency. (2024) European Drug Emergencies Network (Euro-DEN Plus): data and analysis.

European Union Drugs Agency, Society for the Study of Addiction. (2024) Official LxAddictions podcast. In cooperation with the Society for the Study of Addiction (SSA). Lisbon: EUDA.

European Union Drugs Agency. (2024) The impact of economic recessions on the use of illicit drugs: findings from a scoping literature review. Luxembourg: Publications Office of the European Union.

European Union Drugs Agency. (2024) Penalties for drug law offences in Europe at a glance.

European Union Drugs Agency. (2024) Topic overview: penalties at a glance.

European Union Drugs Agency. (2024) Viral hepatitis elimination barometer among people who inject drugs — European overview.

European Union Drugs Agency. (2024) Frequently asked questions (FAQ): drug overdose deaths in Europe.

European Union Drugs Agency. (2024) Frequently asked questions (FAQ): therapeutic use of psychedelic substances.

European Union Drugs Agency. (2024) Drug supply, production and precursors – the current situation in Europe (European Drug Report 2024). Lisbon: EUDA.

European Union Drugs Agency. (2024) Drug-induced deaths – the current situation in Europe (European Drug Report 2024). Lisbon: EUDA.

European Union Drugs Agency. (2024) Drug-related infectious diseases – the current situation in Europe (European Drug Report 2024). Lisbon: EUDA.

European Union Drugs Agency. (2024) Harm reduction – the current situation in Europe (European Drug Report 2024). Lisbon: EUDA.

European Union Drugs Agency. (2024) MDMA – the current situation in Europe (European Drug Report 2024). Lisbon: EUDA.

European Union Drugs Agency. (2024) New psychoactive substances – the current situation in Europe (European Drug Report 2024). Lisbon: EUDA.

European Union Drugs Agency. (2024) Other drugs – the current situation in Europe (European Drug Report 2024). Lisbon: EUDA.

European Union Drugs Agency. (2024) Understanding Europe’s drug situation in 2024 – key developments (European Drug Report 2024). Lisbon: EUDA.

European Union Drugs Agency. (2023) How to run a trends workshop: an EMCDDA foresight toolkit for the drugs field. Lisbon: EUDA.